Sort by

Send to

Choose Destination

Links from PubMed

Items: 14


Quality of Life in Glaucoma: A Review of the Literature.

Quaranta L, Riva I, Gerardi C, Oddone F, Floriano I, Konstas AG.

Adv Ther. 2016 Jun;33(6):959-81. doi: 10.1007/s12325-016-0333-6. Epub 2016 Apr 30. Review. Erratum in: Adv Ther. 2016 Jun;33(6):982.


A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodology.

Waisbourd M, Parker S, Ekici F, Martinez P, Murphy R, Scully K, Wizov SS, Hark LA, Spaeth GL.

BMC Ophthalmol. 2015 Aug 1;15:91. doi: 10.1186/s12886-015-0088-x.


Ophthalmic and Glaucoma Treatment Characteristics Associated With Changes in Health-related Quality of Life Before and After Newly Diagnosed Primary Open-angle Glaucoma in Nurses' Health Study Participants.

Bailey LA, Okereke OI, Kawachi I, Cioffi GA, Pasquale LR, Kang JH.

J Glaucoma. 2016 Mar;25(3):e220-8. doi: 10.1097/IJG.0000000000000304.


Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life.

Inoue M, Arakawa A, Yamane S, Kadonosono K.

Clin Ophthalmol. 2014 Sep 4;8:1711-6. doi: 10.2147/OPTH.S68293. eCollection 2014.


Linguistic and psychometric validation of the Chinese version of the Glaucoma Quality of Life-15 (GQL-15-CHI): a cross-sectional study.

Zhou C, Yao J, Qian S, Wu P.

Health Qual Life Outcomes. 2013 Nov 5;11:188. doi: 10.1186/1477-7525-11-188.


Comparison of visual performance of multifocal intraocular lenses with same material monofocal intraocular lenses.

Yamauchi T, Tabuchi H, Takase K, Ohsugi H, Ohara Z, Kiuchi Y.

PLoS One. 2013 Jun 28;8(6):e68236. doi: 10.1371/journal.pone.0068236. Print 2013.


Identifying areas of the visual field important for quality of life in patients with glaucoma.

Murata H, Hirasawa H, Aoyama Y, Sugisaki K, Araie M, Mayama C, Aihara M, Asaoka R.

PLoS One. 2013;8(3):e58695. doi: 10.1371/journal.pone.0058695. Epub 2013 Mar 8. Erratum in: PLoS One. 2015;10(11):e0144212.


The effect of different criteria on the number of patients blind from open-angle glaucoma.

Heijl A, Aspberg J, Bengtsson B.

BMC Ophthalmol. 2011 Nov 10;11:31. doi: 10.1186/1471-2415-11-31.


Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium.

Varma R, Richman EA, Ferris FL 3rd, Bressler NM.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6095-103. doi: 10.1167/iovs.10-5627. No abstract available.


The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Evans K, Law SK, Walt J, Buchholz P, Hansen J.

Clin Ophthalmol. 2009;3:433-45. Epub 2009 Aug 3.


Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-angle glaucoma.

Wren PA, Musch DC, Janz NK, Niziol LM, Guire KE, Gillespie BW; CIGTS Study Group.

J Glaucoma. 2009 Jun-Jul;18(5):403-11. doi: 10.1097/IJG.0b013e3181879e63.


Health-related quality of life following blind rehabilitation.

Kuyk T, Liu L, Elliott JL, Grubbs HE, Owsley C, McGwin G Jr, Griffin RL, Fuhr PS.

Qual Life Res. 2008 May;17(4):497-507. doi: 10.1007/s11136-008-9336-3.


Practical recommendations for measuring rates of visual field change in glaucoma.

Chauhan BC, Garway-Heath DF, Goñi FJ, Rossetti L, Bengtsson B, Viswanathan AC, Heijl A.

Br J Ophthalmol. 2008 Apr;92(4):569-73. doi: 10.1136/bjo.2007.135012. Epub 2008 Jan 22. Review.


The rising cost of glaucoma drugs.

Azuara-Blanco A, Burr J.

Br J Ophthalmol. 2006 Feb;90(2):130-1. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk